Search
Neurogene Inc
NGNEAdd to Watchlist
31.530USD
+0.740+2.40%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
488.39MMarket Cap
LossP/E TTM
Neurogene Inc's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Neurogene Inc is 7.69, ranking 207 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -6.94, which is -890.57% below the recent high of 54.85 and -159.07% above the recent low of -17.97.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
